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Introduction
Transplantology as a medical science and transplanta-
tion per se have recorded a significant progress over the past 
decades. In analysts’ opinion, transplantation is an indicator 
of the level of development of medical industry, the scientif-
ic and practical potential of a state and the level of maturity 
of society [1]. As to organs, the demand for certain types of 
tissues and cells to be transplanted goes beyond the avail-
able supply.
World Health Organization (WHO) presented two re-
ports – First and Second Global Consultation on Regulatory 
Requirements for Human Cells and Tissues for Transplan-
tation (2004 and 2006, respectively) providing an overview 
regarding the relevance and development of this field in dif-
ferent countries. The First WHO Report defines the tissue 
and cell grafts as a specific class of medical products with 
an important therapeutic value where almost no substitutes 
for restoring vital functions exist [2]. Many countries face 
a deficit of standards and regulations relevant for this field 
and they also face a lack of necessary grafts, for instance cor-
neal grafts. The other Report highlights the importance of 
systems safe for traceability and biovigilance, underlining 
the fact that, for instance, annually, in Spain almost 10.000 
patients get bone, tendon or corneal grafts [3].
The American Association of Tissue Banks (AATB), 
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Abstract
Background: Safe and sustainable supply of tissues and cells for human application is an essential pillar in modern medical assistance and a priority for 
the health authorities both at national and international level. 
Material and methods: The study protocol for the needs assessment in tissue and cell grafts for the healthcare system was approved by the Ethic Committee. 
The survey of 161 surgeons was carried out in 24 institutions, through specially developed questionnaires. In order to validate some data obtained through 
questionnaires, the analysis of already existing national data and sources was performed.
Results: Most surgeons (93.4%) declare that the institution they work at has been provided with a sufficient number of grafts for all patients needing 
transplantation. Despite this, the estimation of surgeons’ opinion regarding the need for grafts showed that 59.4% of respondents consider that they have 
enough grafts, 21.7% of respondents deal with exceptional cases of lack of grafts, 13.2% respondents consider that there are sufficient grafts for urgent 
patients and, sometimes, for non-urgent patients.
Conclusions: The study revealed that increasing the number of tissue transplantations will contribute to improve the patients’ life quality and increasing 
the number of transplanted patients over the next 5 years is a priority measure in the management of the institutions included in the survey.
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which includes more than 120 accredited tissue banks, says 
that the tissue banks have been established to satisfy critical 
medical needs for tissue grafts in order to save or to improve 
life of more than a million Americans yearly [4].
AATB’s Activity Report for 2017 shows that over the last 
10 years there has been noted a general increase in donors 
and grafts procurement. The total number of actual tissue 
donors (both alive and deceased ones) has rapidly increased 
by 92%: from 30.380 in 2007 up to 58.339 in 2015. The total 
number of grafts distributed has also gone up from 2.496.010 
in 2007 up to 3.294.066 in 2015, representing 32% [4, 5]. 
The musculoskeletal grafts remain to be the most requested 
ones and represent 71% of the total number of tissues dis-
tributed in 2015. In the period 2012-2015, the number of 
grafts distributed registered a rise in those 5 categories out 
of six in whole, except for cardiac tissues: musculoskeletal, 
skin, soft tissues, vessel, tissues from alive donors have in-
creased up to 122%.
 Spain has the highest number of deceased donors. If 
in the middle of the ‘90’s, it counted 27 donors per million 
populations (pmp), in 2017 this rate went up to 46.9 pmp [6, 
7]. Tissue donation has increased in the period 2011 – 2016: 
cornea – from 60 pmp up to 82.4 pmp, musculoskeletal tis-
sue – from 44.8 pmp up to 57 pmp, skin tissue – from 4.5 
pmp up to 7.3 pmp [8, 9].
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Croatia has successfully introduced different elements 
of the best European practices (Spanish model, Eurotrans-
plant system, etc.) and recorded a sustainable increase in the 
rate of pmp donors, registering in 2017 a rate of 33 donors 
pmp [10]. In 2011 – 2016, the corneal tissue donors have 
increased significantly from 2.7 pmp up to 69.9 pmp [8, 9]. 
In other European Union countries (EU countries), 
the number of donors and tissues transplants have also in-
creased. For instance, in France, in the period 2011-2016, 
the tissue donation has significantly increased, namely the 
musculoskeletal tissue from 1.3 pmp up to 402 pmp, the 
number of grafts distributed for transplantation has risen 
from 27997 up to 47528, representing 41% [8, 9].
The increase in possibility to use human material in vari-
ous forms for the others’ benefit during the medical treat-
ment has put significant pressure on the EU countries to 
satisfy this demand. The demand of human material is ob-
viously variable as scientific developments make available 
more forms of treatment, it is likely that demand for such 
treatment to go up, meanwhile the development of alter-
nate forms of treatment could result in decrease of demand. 
People’s expectations as to what the medical sciences could 
reach put additional pressure on that supply [11].
Safe and sustainable supply of tissues and cells is an es-
sential pillar in modern medical assistance in the EU coun-
tries and a priority for the health authorities both at national 
and the EU level [12-14]. In more situations, a tissue or cell 
transplant is the best or the single therapeutic option for 
patients. The supply and offer of human tissues and cells is 
a task of management during which medical, financial and 
social aspects should be constantly balanced as for the or-
ganization to continue to work and to be accepted by society 
[15]. 
The history in different types of tissue and cell banks un-
derscore the complicated and interconnected ways the tis-
sues and cells donated by one person may be used to help 
others or themselves [16, 17].
The main aim to preserve human material for trans-
plantation in a bank is to satisfy the clinical demand of tis-
sues and cells [18, 19]. The national health authorities are 
responsible to ensure that the patients’ needs are satisfied 
with a safe, qualitative and appropriate source of tissues and 
cells [20]. 
The goal of this study was to assess the needs for tissue 
and cell grafts for the healthcare system in order to ensure 
the functioning of the transplant services provided to the 
population.
Material and methods
The study was performed to evaluate the opinions of the 
doctors of surgical profile, whether or not involved in the 
transplant services, regarding the needs for tissue and cell 
grafts for the healthcare system, through specially devel-
oped questionnaires, consisting of 35 questions. The volume 
of the representative sample of the doctors of surgical profile 
was calculated based on the classical formula, proposed for 
the random non-repetitive survey with an admitted error of 
5% and a non-response rate of 10.0%. In order to validate 
some data obtained through questionnaires, we used the 
case studies and the analysis of already existing national data 
and sources. The study protocol was approved by the Ethic 
Committee of the Nicolae Testemitsanu State University of 
Medicine and Pharmacy, Chisinau (No. 2, 27.10.2016).
The survey of 161 doctors of surgical profile aged 25 – 81 
was carried out in 24 medical-sanitary institutions, includ-
ing 20 public institutions (9 republican, 2 municipal and 9 
district) and 4 private institutions. In order to carry out the 
tissue and cell donation and transplantation activities, 10 
from 24 medical-sanitary institutions are authorized by the 
Ministry of Health: 8 public and 2 private institutions. Their 
annual activity reports submitted to the Transplant Agency 
were used for the analysis.
In the group of doctors of surgical profile were included: 
24 (14.9%) transplant coordinators and persons in charge 
of transplantation from medical-sanitary institutions with 
activities in the field of tissues and cells donation and trans-
plantation, 52 (32.3%) orthopaedic  traumatologists, 27 
(16.8%) general surgeons, 15 (9.3%) ophthalmologists, 7 
(4.3%) combustiologists, 36 (22.4%) doctors with another 
surgical profile – oncologists, neurosurgeons, gynecologists, 
urologists.
Of the total number of surgeons, 125 (77.6%) were men 
and 36 (22.4%) were women. Depending on age and gen-
der, the respondents in the study group were distributed 
as follows: 25 (15.5%) persons were aged within 25 – 34 
years (15 – 60.0% men and 10 – 40.0% women), 93 (57.8%) 
persons – within 35 – 54 years (73 – 78.5% men and 20 – 
21.5% women), 43 (26.7%) persons – within 55 – 81 years 
(37 – 86.0% men and 6 – 14.0% women). The average age of 
surgeons was 46.84 ± 0.9 years. The average age was statisti-
cally significantly higher in men – 47.78 ± 0.9 years, com-
pared with women – 43.58 ± 2.1 years (from 25 to 70 years; 
p <0.05).
Statistical processing of the material was based on the 
special files elaborated where the primary data were coded – 
the results of the questionnaires, the data from the primary 
documents of the medical-sanitary institutions and the data 
from the databases of the Transplant Agency. The primary 
materials of the study were computerized using the software 
”Statistical Package for the Social Science” version 20.0 for 
Windows (SPSS, Inc., Chicago, IL, 2011) by methods of 
variation, correlation and discriminant analysis. Differences 
with the bilateral p-value <0.05 were considered statistically 
significant.
Results and discussion
To assess the needs for tissue and cell grafts, 139 (86.3%) 
surgeons from the public medical-sanitary institutions and 
22 (13.7%) surgeons from the private medical-sanitary in-
stitutions have been interviewed. Out of the mentioned 
surgeons, 106 (65.8%) respondents were from the medical–
sanitary institutions with activities in the field of tissues and 
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cells donation and transplantation, and 55 (34.2%) respond-
ents were from the medical-sanitary institutions without ac-
tivities in this field. 
The survey showed that to carry out donation and trans-
plantation activities does not depend on the type of financ-
ing, legal form of medical institution: 13 (59.1%) respond-
ents confirmed that transplant services are provided in 
private institutions and 93 (66.9%) respondents – in public 
institutions (p>0,05).
 The estimate of frequency of different transplant types 
made was taken from the annual activity reports by the 
medical-sanitary institutions and based on the opinion of 
surgeons from the medical-sanitary institutions included in 
the survey.
Most surgeons – 99 (93.4%) – say that the institution 
they work at has been provided with a sufficient number of 
tissue grafts for all patients needing transplantation. Only 
7 (6.6%) respondents consider that the provided tissue 
grafts are insufficient. Respondents from the public medi-
cal-sanitary institutions say that they are provided with suf-
ficient tissue grafts to cover all patients needing transplant, 
statistically more frequently compared to respondents from 
private institutions: 91 (97.8%) and 8 (61.5%), respectively; 
p <0.001). 
Despite this, the estimation of surgeons’ opinion regard-
ing the need for grafts showed the following: 63 (59.4%) 
respondents consider that their institutions have enough 
grafts, 23 (21.7%) respondents consider that their institu-
tions deal with exceptional cases of lack of grafts, 14 (13.2%) 
respondents consider that there are sufficient grafts for ur-
gent patients and, sometimes, for non-urgent patients, and 6 
(5.7%) respondents consider that grafts are enough only for 
patients in emergency need (fig. 1).
Fig. 1.  Surgeons’ opinion regarding the need for grafts (%).
The need to develop the tissue transplantation, especially 
the cornea transplant, results from the analysis of further in-
crease in the cornea transplant waiting list that is presently 
performed in 5 medical-sanitary institutions with activities 
in the field of tissues and cells donation and transplantation 
[21]. The total annual number of cornea transplantations in 
average is 7.2±3.34 (from 1 up to 19 corneal grafting surge-
ries) (fig. 2).
Over ½ (24 – 51.1%) of surgeons would perform more 
corneal grafting surgeries if such grafts were provided by 
the tissue bank – in average 12.33±1.86 (from 4 up to 15 
corneal grafts). In the private medical-sanitary institutions, 
this parameter is statistically more frequently encounted (6 
– 100.0%) compared to the municipal medical-sanitary in-
stitutions (1 – 16.7%; p<0.001) and the republican medical-
sanitary institutions (17 – 48.6%; p<0.001).
One of the reasons why the donation and transplanta-
tion activities are not performed is that there is no qualified 
medical personnel and appropriate medical equipment. The 
main reasons why the corneal grafting is not performed in 
the public and private medical-sanitary institutions is the 
lack of qualified medical staff and adequate medical equip-
ment, problem that was highlighted by 28 (24.6%) surgeons, 
the lack of qualified medical staff – by 16 (14.0%) surgeons, 
the lack of adequate medical equipment – by 16 (14.0%) 
surgeons and other reasons (the institution is focused on 
other type of transplantation of human tissues or is not au-
thorized to perform such surgeries) were mentioned by 54 
(47.4%) surgeons (fig. 3).
Fig. 3.  The main reasons why the medical-sanitary institutions 
do not perform cornea transplantation (%).  
According to the medical-sanitary institutions’ authori-
zation provided to perform activities in the field of tissues 
and cells donation and transplantation, the following results 
were obtained. Respondents from institutions with activi-
ties in this field mentioned that the corneal grafting is not 
performed due to the fact that there is no qualified medical 
personnel and no adequate medical equipment in 2 (3.4%) 
cases, no qualified medical staff – 10 (16.9%) cases, no ad-
equate medical equipment – 6 (10,2%) cases and the institu-
tion has another transplant profile – 41 (69.5%) cases. Re-
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Fig. 2.  Annual number of tissue and cell transplants 
performed (average value).
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spondents from institutions not performing activities in the 
field of tissues and cells donation and transplantation noted 
that the cornea transplantation is not performed due to the 
absence of qualified medical personnel and adequate medi-
cal equipment – 26 (47.3%) cases, qualified medical staff – 
6 (10.9%) cases, adequate medical equipment – 10 (18.2%) 
cases and authorization for performing donation and trans-
plantation –13 (23.6%) cases (fig. 4).
Fig. 4.  The main reasons why the medical-sanitary institutions 
do not perform cornea transplantation (%) depending 
on the deployment activities in the field of tissue and cell 
donation and transplantation.
 
The musculoskeletal tissue transplantation is performed 
in 6 (60.0%) medical-sanitary institutions with activities in 
the field of tissues and cells donation and transplantation. 
The total annual number of musculoskeletal tissue grafting 
surgeries is in average of 21.83±6.48 (from 1 up to 43 mus-
culoskeletal tissue grafting surgeries) (fig. 2). The cancellous 
bone or cortical bone transplantation was mentioned by 25 
(32.9%) surgeons, where the bone and tendon transplanta-
tion was mentioned by 51 (67.1%) surgeons. Over 2/5 (34 
– 44.7%) of surgeons would perform more musculoskeletal 
tissue grafting surgeries if those grafts were offered by the tis-
sue bank. As to the republican medical-sanitary institutions 
this parameter is statistically more frequent (32 – 50.0%) 
compared to the private institutions (0 – 0%; p<0.001).
Moreover, over 4/5 (67 – 88.2%) of surgeons will need 
the provided bone grafts in other forms than the frozen ones 
(lyophilized, demineralized, morsel): statistically less often 
in the republican medical-sanitary institutions (55 – 85.9%) 
against private ones (7 – 100.0%; p<0.01) and municipal 
ones (5 – 100.0%; p<0.01). 
Wang W, Yeung KW. highlight that autologous bone 
graft is the gold standard clinical material for bone regener-
ation. However, limited availability and donor site morbid-
ity are concerned. Bone allograft becomes the second higher 
option for orthopaedic procedures due to the availability in 
various forms and large quantities [22]. 
Skin transplantation is performed in 2 (20.0%) medical-
sanitary institutions with activities in the field of tissues 
and cells donation and transplantation. Annually there are 
performed skin grafting surgeries 10.0±1.0 (from 9 up to 11 
surgeries) in average (fig. 2), with 71.5±0.5 grafts (from 71 
up to 72 grafts) on a surface of 11005.0±358.5 cm2 (from 
10647 up to 11364 cm2). 
Over 1/2 (23 – 57.5%) of surgeons would perform more 
skin grafting surgeries if those grafts were provided by the 
tissue bank. All respondents are hired by the republican 
medical-sanitary institutions.
The amniotic membrane transplantation is performed 
in 6 (60.0%) medical-sanitary institutions with activities in 
the field of tissues and cells donation and transplantation. 
The total annual number of amniotic membrane transplan-
tations in average is of 10.67±6.72 (from 3 up to 44 amni-
otic membrane grafting surgeries) (fig. 2), with 11.83±6.55 
grafts (from 3 up to 44 grafts) on a surface of 559.0±279.16 
cm2 (from 45 up to 1814 cm2).
Over 1/2 (39 – 52.7%) of surgeons would perform more 
amniotic membrane grafting surgeries if those grafts were 
provided by the tissue bank – in average 7.75±0.75 grafts 
(from 7 up to 10 grafts). In the private medical-sanitary 
institutions this parameter is statistically more frequent 
(6 – 100.0%) compared to the municipal institutions (0 – 
0%; p<0.001) and the republican institutions (33 – 53.2%; 
p<0.001). 
Our study showed that musculoskeletal grafts for trans-
plant surgery remain the most requested in our country as 
in the other countries of the world [5, 9].
Generally, 100 (94.3%) surgeons from the medical-san-
itary institutions with activities in the field of tissues and 
cells donation and transplantation consider that the increas-
ing in number of tissue grafting surgeries performed in their 
institutions would contribute to improve the patients’ life 
quality. As to the republican medical-sanitary institutions, 
this opinion is statistically less often (76 – 92.7%), compared 
to the municipal institutions (11 – 100.0%; p<0.05) and pri-
vate institutions (13 – 100.0%; p<0.05) (fig. 5).
About 64 (94.1%) surgeons from the medical-sanitary 
institutions with activities in the field of tissues and cells do-
nation and transplantation declared that enlarging the types 
of tissues transplanted is a very necessary measure. This 
opinion is also shared (p>0.05) by respondents from the re-
publican (55 – 94.8%), municipal (4 – 80.0%) and private 
(5 – 100.0%) institutions.
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Fig. 5.  Opinion of surgeons from the medical-sanitary 
institutions with transplant activities regarding the perspective 
of tissues and cells transplantation (%).
Over 2/3 (117 – 72.7%) of surgeons from all medical-
sanitary institutions participating in the survey consider 
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that increasing the number of transplanted patients in the 
next 5 years is a priority for the institution management. 
This opinion is also shared by surgeons from the institutions 
with activities in the field of tissues and cells donation and 
transplantation (80 - 75.5% of respondents) and from the 
institutions without the activities in this field (37 – 67.3% of 
respondents; p>0.05).
Despite this, only about 2/3 (68 – 64.2%) of respondents 
plan in the next 5 years to extend the types of tissue and cell 
grafting (other than those transplanted currently): 5 (45.5%) 
respondents from the municipal institutions, 5 (38.5%) re-
spondents from the private institutions and 58 (70.7%) re-
spondents from the republican institutions (fig. 6).
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Fig. 6.  Surgeons’ plan to extend the types of tissues and cells 
transplanted over the next 5 years by institution level (%).
This expectation is statistically more frequent among 
surgeons from the republican medical-sanitary institutions 
– 58 (70.7%) respondents compared to surgeons from the 
private institutions – 5 (38.5%) respondents (p<0.05).
The assessment of opinion of surgeons regarding the 
dynamic of providing those institutions with tissue grafts 
over the past 5 years found that 81 (76.4%) respondents 
confirmed that situation has improved and 25 (23.6%) re-
spondents consider that it has not changed. Depending on 
the level of institution, the followi g results were achieved: 
64 (78.0%) respondents from the republica  medical-sani-
tary institutions, 11 (100.0%) respondents from the munici-
pal institutions and 6 (46.2%) respondents from the private 
institutions consider that situation in providing the institu-
tion with tissue grafts over the last 5 years has improved; 
18 (22.0%) respondents from the republican institutions 
and other 7 (53.8%) respondents from the private institu-
tions consider that situation with providing grafts has not 
changed over the past 5 years. Statistically significant dif-
ferences in those opinions as to tissue grafts provided to the 
institutions were noted in respondents from the munici-
pal and private institutions (p<0.01), in respondents from 
the municipal and republican institutions (p<0.01) and in 
respondents from the private and republican institutions 
(p<0.05) (fig. 7).
About 2/3 (66 – 62.3%) of surgeons from the medical-
sanitary institutions with activities in the field of tissues and 
cells donation and transplantation declare that the number 
of patients needing transplant has increased, 38 (35.8%) 
respondents consider that the number of patients needing 
transplant has unchanged and only 2 (1.9%) respondents 
mentioned that the number of patients needing transplant 
has decreased. As many as 51 (62.2%) respondents from 
the republican institutions, 9 (81.8%) respondents from the 
municipal institutions and 6 (46.2%) respondents from the 
private institutions revealed that number of patients who 
need grafting has increased, 29 (35.4%) respondents from 
the republican institutions, 2 (18.2%) respondents from the 
municipal institutions and 7 (53.8%) respondents from the 
private institutions declared that the number of patients in 
need of a transplant has remained unchanged and only 2 
(2.4%) respondents from the republican institutions noted 
that the number of patients who need transplant has de-
creased. Differences in those opinions could not be set sta-
tistically significant (fig. 8).
Therefore, priority in establishing an efficient tissue and 
cell transplantation system should be given to: promoting 
the training of specialists based on the best experiences, 
endowing the medical-sanitary institutions with adequate 
medical equipment, establishing an efficient system for 
identifying persons that could become tissue donors post-
mortem and studying how to encourage donors alive to do-
nate [11, 16, 23, 24].
Fig. 8.  Opinion of surgeons regarding the dynamics of the 
number of patients requiring transplantation according to the 
institution level (%).
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Fig. 7.  The opinion of surgeons regarding the dynamic  
of providing with tissue grafts during the last 5 years  
depending on the level of the institution (%).
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Conclusions
1. The estimation of surgeons’ opinion regarding the 
clinical needs for tissues and cells revealed the following: 
59.4% of respondents consider that their institutions are 
sufficiently supplied with grafts, 21.7% of respondents con-
sider that their institutions deal with exceptional cases of 
lack of grafts, 13.2% respondents consider that the grafts are 
sufficient for urgent patients and 5.7% respondents consider 
that grafts are enough only for patients in emergency need.
2. About 44.7-57.5% of surgeons from the medical-san-
itary institutions with activities in the field of tissues and 
cells donation and transplantation would transplant more 
grafts if those grafts were provided by the tissue bank, and 
64.2% of surgeons plan to extend the types of transplanted 
tissues and cells (other than those transplanted currently) 
over the next 5 years. 
3. About 94.3% of surgeons from the medical-sanitary 
institutions with activities in the field of tissues and cells do-
nation and transplantation consider that the increasing in 
number of tissue transplants performed will contribute to 
improve the patients’ life quality, 94.1% of surgeons declare 
that enlarging the types of tissues transplanted is a neces-
sary measure, and 72.7% of surgeons are convinced that in-
creasing the number of transplanted patients over the next 5 
years is a priority measure in the management of the institu-
tion they operate.
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